Cabazitaxel plus carboplatin for the treatment of men with metastatic castration-resistant prostate cancers: a randomised, open-label, phase 1–2 trial

Research output: Contribution to journalArticlepeer-review

105 Scopus citations

Fingerprint

Dive into the research topics of 'Cabazitaxel plus carboplatin for the treatment of men with metastatic castration-resistant prostate cancers: a randomised, open-label, phase 1–2 trial'. Together they form a unique fingerprint.

Medicine & Life Sciences